Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Engineering Human Pluripotent Stem Cell-Derived Natural Killer Cells to Prevent CD16a Shedding for Enhanced Anti-Tumor Killing

Robert Blum, MS, Aadithya Arumugam, PhD, Jianming Wu, DVM, PhD, Bruce Walcheck, PhD, Dan Kaufman, MD PhD

Blood (2016) 128 (22): 1336.

https://doi.org/10.1182/blood.V128.22.1336.1336

Published: 2016

Journal Articles

Exome Sequencing Identifies Recurring DNMT3A Mutations in Adult ETP-ALL

Martin Neumann, MD, Sandra Heesch, PhD, Cornelia Schlee, MS, Stefan Schwartz, MD, Nicola Goekbuget, MD, Dieter Hoelzer, MD, Nikola P Konstandin, Bianka Ksienzyk, Alexander Graf, Stefan Krebs, PhD, Helmut Blum, PhD, Thorsten Raff, MD, Monika Brueggemann, Wolf-Karsten Hofmann, Stefan K Bohlander, MD, Philipp A Greif, MD, Claudia D Baldus

Blood (2012) 120 (21): 1377.

https://doi.org/10.1182/blood.V120.21.1377.1377

Published: 2012

Journal Articles

CMV-Specific T-Cells Are More Effective Than WT-1-Specific T-Cells in Eradicating Clonogenic Tumor Cells Co-Expressing CMVpp65 and WT-1 in-Vivo and Both Types of T-Cells Are Functionally Augmented in the Presence of IL-15/IL-15Rα

Aisha Hasan, MD, Dana Bakalar, B.S, Annamalai Selvakumar, PhD, Gloria C Koo, PhD, Ekaterina Doubrovina, MD, PhD, Tzu-Yun Kuo, M.S, Richard J. O'Reilly, MD

Blood (2011) 118 (21): 646.

https://doi.org/10.1182/blood.V118.21.646.646

Published: 2011

Journal Articles

MARCKS Confers Resistance to Velcade Through Skp2/p27-Mediated Pathway in Multiple Myeloma

Yijun Yang, Johann Micallef, Hong Chang

Blood (2011) 118 (21): 985.

https://doi.org/10.1182/blood.V118.21.985.985

Published: 2011

Journal Articles

Enhanced Antitumor Efficacy of MUC-16 Targeted T Cells Further Modified to Constitutively Express the IL-12 Cytokine in a Syngeneic Model of Ovarian Cancer,

Alena A Chekmasova, PhD, Samith Sandadi, MD, David R Spriggs, MD, Renier J Brentjens, MD, PhD

Blood (2011) 118 (21): 4176.

https://doi.org/10.1182/blood.V118.21.4176.4176

Published: 2011

Journal Articles

Eltrombopag Decreases Proliferation of Ovarian, Lung and Breast Tumor Cell Lines.

Connie L. Erickson-Miller, Jennifer Kirchner, Kodandaram Pillarisetti, Lone Ottesen, Yasser Mostafa Kamel, Yuan Liu, Anne-Marie Martin, Conrad Messam

Blood (2009) 114 (22): 2409.

https://doi.org/10.1182/blood.V114.22.2409.2409

Published: 2009

Journal Articles

A Specific Gene Expression Signature Affecting the Beta-Catenin and Notch Signaling Pathways and the Downregulation of MALAT1 Prove Acute Myeloid Leukemia with Limited Differentiation (AML-LD) as a Distinct Entity with NPM1 Mutation.

Wolfgang Kern, MD, Vera Grossmann, MA, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2009) 114 (22): 164.

https://doi.org/10.1182/blood.V114.22.164.164

Published: 2009

Journal Articles

The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D

Yan Kong, Wei Cao, Xueyan Xi, Chi Ma, Lianxian Cui, Wei He

Blood (2009) 114 (2): 310–317.

https://doi.org/10.1182/blood-2008-12-196287

Published: 2009

Journal Articles

HIF-1a Expression and Implication in the Resistance Regulation and Malignancy in Pediatric Lymphomas Non-Hodgkin’s Tissue Arrays

Rosendo Luria-Pérez, Ph.D., Yolanda Rocio Peña-Alonso, M.D., Daniel Dimitri Hernández-Cueto, B.Sc., Altagracia Maldonado-Valenzuela, B.Sc., Guillermina Juliana Baay-Guzmán, B.Sc., Guadalupe Diaz-Elizondo, B.Sc., Luis Andrés Lara-Martínez, B.Sc., Glenda Juárez-Caballero, M.D., Mario I. Vega, PhD, Benjamin Bonavida, PhD, Sara Huerta-Yepez, Ph.D.

Blood (2008) 112 (11): 5308.

https://doi.org/10.1182/blood.V112.11.5308.5308

Published: 2008

Journal Articles

Genetic Polymorphisms of DNA-Repair- and Detoxification Enzymes in Therapy-Related AML and MDS.

Stephanie Fischer, Claire Seedhouse, PhD, Thomas Schulz, PhD, Ulrich Germing, PhD, MD, Lorenz H. Truemper, PhD, MD, Detlef Haase, PhD, MD

Blood (2007) 110 (11): 4223.

https://doi.org/10.1182/blood.V110.11.4223.4223

Published: 2007

Journal Articles

Ancestim (r-metHuSCF) Plus Filgrastim for the Mobilization and Collection of Peripheral Blood Progenitor Cells for Autologous Transplant after Failure of Prior Mobilization: The French Experience of Compassionate Use.

Valerie Lapierre, MD, PhD, Christian Chabannon, MD, Caroline Makowski, MD, Cecile Dumesnil, MD, Dominique Valteau-Couanet, MD, PhD, Anne Vekhoff, MD, Denis Caillot, MD, Nabih Azar, MD, Marine Divine, MD, Karin Blakolmer, MD, Christian Cailliot, MD, Philippe Moreau, MD, PhD, Jean-Francois Rossi, MD, PhD

Blood (2007) 110 (11): 3281.

https://doi.org/10.1182/blood.V110.11.3281.3281

Published: 2007

Journal Articles

A Phase III, Randomized, Double-Blind, Placebo-Controlled Comparative Trial of Pegfilgrastim Versus Filgrastim after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT).

Aaron Gerds, MD, Mary Fox-Geiman, PharmD, Kevin Dawravoo, MD, Tulio Rodriguez, MD, Amir Toor, MD, Scott Smith, MD, PhD, Donna Fletcher-Gonzales, RPh, Chindo Hicks, PhD, Patrick Stiff, MD

Blood (2007) 110 (11): 479.

https://doi.org/10.1182/blood.V110.11.479.479

Published: 2007

Journal Articles

Stimulation of Anti-Tumor Immunity Using Dendritic Cells Transduced with Fowl Pox Vector Expressing MUC-1 and Costimulatory Molecules (PANVAC-F).

Baldev Vasir, PhD, Corrine Lenahan, MD, Jacalyn Rosenblatt, MD, Adam Bissonnette, Zekui Wu, MD, Donald Kufe, MD, David Avigan, MD

Blood (2006) 108 (11): 5209.

https://doi.org/10.1182/blood.V108.11.5209.5209

Published: 2006

Journal Articles

Targeting of Heat Shock Protein 32 (Hsp32) in Neoplastic Cells by Styrene Maleic Acid Zinc Protoporphyrin (SMA-ZnPP) Is Associated with Reduced Growth and Induction of Apoptosis.

Karoline V. Gleixner, MD, Mayerhofer Matthias, MD, Anja Vales, MD, Alexander Gruze, Michael Kneidinger, MD, Gregor Hoermann, Maria T. Krauth, MD, Rudin Kondo, MD, Karoline Sonneck, MD, Puchit Samorapoompichit, MD, Eva Lackner, MD, Khaled Greish, PhD, Winfried F. Pickl, MD, Christian Sillaber, MD, Christoph C. Zielinski, MD, Hiroshi Maeda, MD, Peter Valent, MD

Blood (2006) 108 (11): 4323.

https://doi.org/10.1182/blood.V108.11.4323.4323

Published: 2006

Journal Articles

Mesenchymal Stem Cells Selectively Engraft into Tumor Stroma and Produce Potent Antitumor Proteins In Situ.

Michael Andreeff, MD, PhD, Jennifer Dembinski, Brett M. Hall, Ph.D., Matus Studeny, M.D., Xiaoyang Ling, Ph.D., Maria Cabreira-Hansen, Ph.D., A. Kate Sasser, Teresa McQueen, Frederick Lang, M.D., Frank C. Marini, Ph.D.

Blood (2006) 108 (11): 352.

https://doi.org/10.1182/blood.V108.11.352.352

Published: 2006

Journal Articles

Immunotherapy of Primary Ovarian Cancer Using Autologous Cytokine Induced Killer Cells Retargeted with Bispecific Antibodies: A Preclinical Study.

John K. Chan, MD, Chad A. Hamilton, MD, Michael K. Cheung, BA, Mobin Karimi, MS, Jeanette Baker, PhD, Jonathan M. Gall, BA, Lawrence G. Lum, MD, Stephan Schulz, MD, Steve H. Thorne, PhD, Nelson N. Teng, MD, PhD, Christopher H. Contag, PhD, Robert S. Negrin, MD

Blood (2005) 106 (11): 2379.

https://doi.org/10.1182/blood.V106.11.2379.2379

Published: 2005

Journal Articles

The Telomerase Template Antagonist GRN163L in Combination with Chemotherapeutics Reduces Tumor Volume in Multiple Myeloma Xenograft Models.

Server A. Ertem, BS, Kaida Wu, MD, Vladimir Ponomarev, PhD, Allison C. Chin, PhD, Malcolm A.S. Moore, PhD

Blood (2005) 106 (11): 3477.

https://doi.org/10.1182/blood.V106.11.3477.3477

Published: 2005

Journal Articles

Sequential Treatment with 5-Azacytidine, Valproic Acid (VPA), and All-Trans Retinoic Acid (ATRA) in Patients with High-Risk Acute Myeloid Leukemia (AML).

Emmanuel Raffoux, Adrienne de Labarthe, Claude Gardin, Marie-Therese Daniel, Christine Chomienne, Pierre Fenaux, Laurent Degos, Herve Dombret

Blood (2005) 106 (11): 2798.

https://doi.org/10.1182/blood.V106.11.2798.2798

Published: 2005

Journal Articles

In Vivo Tracking of Macrophage Activated Killer Cells to Sites of Metastatic Ovarian Carcinoma.

David S. Ritchie, MBBS, PhD, FRACP, FRCPA, Linda Mileshkin, MBBS, FRACP, Dominic M. Wall, PhD, Jacques Bartholyens, PhD, Mick Thompson, BSc, Rod Hicks, MBBS, MD, FRACP, Miles Prince, MBBS, MD, FRACP, FRCPA

Blood (2005) 106 (11): 3874.

https://doi.org/10.1182/blood.V106.11.3874.3874

Published: 2005

Journal Articles

GRN163L Inhibits Telomerase Activity in B-CLL Cells.

Claudia Lin, PhD, Rajendra N. Damle, PhD, Nicholas Chiorazzi, PhD, Allison C. Chin, PhD

Blood (2005) 106 (11): 5041.

https://doi.org/10.1182/blood.V106.11.5041.5041

Published: 2005

NARROW

Engineering Human Pluripotent Stem Cell-Derived Natural Killer Cells to Prevent CD16a Shedding for Enhanced Anti-Tumor Killing

Exome Sequencing Identifies Recurring DNMT3A Mutations in Adult ETP-ALL

CMV-Specific T-Cells Are More Effective Than WT-1-Specific T-Cells in Eradicating Clonogenic Tumor Cells Co-Expressing CMVpp65 and WT-1 in-Vivo and Both Types of T-Cells Are Functionally Augmented in the Presence of IL-15/IL-15Rα

MARCKS Confers Resistance to Velcade Through Skp2/p27-Mediated Pathway in Multiple Myeloma

Enhanced Antitumor Efficacy of MUC-16 Targeted T Cells Further Modified to Constitutively Express the IL-12 Cytokine in a Syngeneic Model of Ovarian Cancer,

Eltrombopag Decreases Proliferation of Ovarian, Lung and Breast Tumor Cell Lines.

A Specific Gene Expression Signature Affecting the Beta-Catenin and Notch Signaling Pathways and the Downregulation of MALAT1 Prove Acute Myeloid Leukemia with Limited Differentiation (AML-LD) as a Distinct Entity with NPM1 Mutation.

The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D

HIF-1a Expression and Implication in the Resistance Regulation and Malignancy in Pediatric Lymphomas Non-Hodgkin’s Tissue Arrays

Genetic Polymorphisms of DNA-Repair- and Detoxification Enzymes in Therapy-Related AML and MDS.

Ancestim (r-metHuSCF) Plus Filgrastim for the Mobilization and Collection of Peripheral Blood Progenitor Cells for Autologous Transplant after Failure of Prior Mobilization: The French Experience of Compassionate Use.

A Phase III, Randomized, Double-Blind, Placebo-Controlled Comparative Trial of Pegfilgrastim Versus Filgrastim after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT).

Stimulation of Anti-Tumor Immunity Using Dendritic Cells Transduced with Fowl Pox Vector Expressing MUC-1 and Costimulatory Molecules (PANVAC-F).

Targeting of Heat Shock Protein 32 (Hsp32) in Neoplastic Cells by Styrene Maleic Acid Zinc Protoporphyrin (SMA-ZnPP) Is Associated with Reduced Growth and Induction of Apoptosis.

Mesenchymal Stem Cells Selectively Engraft into Tumor Stroma and Produce Potent Antitumor Proteins In Situ.

Immunotherapy of Primary Ovarian Cancer Using Autologous Cytokine Induced Killer Cells Retargeted with Bispecific Antibodies: A Preclinical Study.

The Telomerase Template Antagonist GRN163L in Combination with Chemotherapeutics Reduces Tumor Volume in Multiple Myeloma Xenograft Models.

Sequential Treatment with 5-Azacytidine, Valproic Acid (VPA), and All-Trans Retinoic Acid (ATRA) in Patients with High-Risk Acute Myeloid Leukemia (AML).

In Vivo Tracking of Macrophage Activated Killer Cells to Sites of Metastatic Ovarian Carcinoma.

GRN163L Inhibits Telomerase Activity in B-CLL Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only